Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours
From MaRDI portal
Publication:2013482
Recommendations
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Drug resistance in cancer chemotherapy as an optimal control problem
- An adaptive pharmacokinetic optimal control approach in chemotherapy for heterogeneous tumor
- On optimal chemotherapy for heterogeneous tumors
- scientific article; zbMATH DE number 1114142
Cites work
- A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment
- A mathematical model of the effects of drug resistance in cancer chemotherapy
- A stochastic model for the origin and treatment of tumors containing drug-resistant cells
- Drug resistance in cancer chemotherapy as an optimal control problem
- Introduction to the mathematical theory of control
- Mathematical model of cancer growth controled by metronomic chemotherapies
- Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
- Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- On optimal delivery of combination therapy for tumors
- Singular trajectories and their role in control theory
- Studying the emergence of invasiveness in tumours using game theory
Cited in
(26)- Modelling chemotherapy resistance in palliation and failed cure
- Combination therapies and intra-tumoral competition: insights from mathematical modeling
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy
- Spreading speeds for a two-species competition-diffusion system
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
- What does not kill a tumour may make it stronger: \textit{in silico} insights into chemotherapeutic drug resistance
- The contribution of evolutionary game theory to understanding and treating cancer
- The effect of random dispersal on competitive exclusion - a review
- A computational study of combination HIFU-chemotherapy as a potential means of overcoming cancer drug resistance
- Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures
- Estimation of drug and tumor properties using novel hybrid meta-heuristic methods
- Optimal chemotherapy schedules from tumor entropy
- Combination of direct methods and homotopy in numerical optimal control: application to the optimization of chemotherapy in cancer
- Scheduling Chemotherapy: Catch 22 between Cell Kill and Resistance Evolution
- Why is evolution important in cancer and what mathematics should be used to treat cancer? Focus on drug resistance
- Efficiency of cancer treatments: \textit{in silico experiments}
- The impact of competition between cancer cells and healthy cells on optimal drug delivery
- An adaptive pharmacokinetic optimal control approach in chemotherapy for heterogeneous tumor
- Optimal releases for population replacement strategies: application to Wolbachia
- Tumor containment: a more general mathematical analysis
- Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent
- Controllability in a class of cancer therapy models with co-evolving resistance
- Optimising the tumour elimination payoff in cancer therapy
- Employing nullclines to balance treatment efficacy and neurotoxicity for sustained tumor control
- Stability of the Darwinian dynamics: effect of intraspecific competition and human intervention
- Asymptotic dynamics and optimal treatment for a model of tumour resistance to chemotherapy
This page was built for publication: Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2013482)
